The Daily Aus (TDA) has launched Investigating Ozempic examining the complex ethical and commercial landscape of medical weight loss. Hosted and produced by TDA’s Features Editor Emma Gillespie this three episode podcast looks at Australia’s medical weight-loss industry and how young people are engaging with high-profile examples like Ozempic, Wegovy and Mounjaro. 

With interviews, firsthand accounts, and commentary from health professionals around patient care and safety protocols, host Emma Gillespie said:

“Ozempic has dominated headlines over recent years, but the experience of young Australians has been missing from the conversation. We received overwhelming feedback from our audience, including hundreds of lived-experience anecdotes, warranting further scrutiny into how these medications are being prescribed, monitored and marketed to young people. This series aims to provide clarity and context to an issue that touches many aspects of young people’s lives.”

A survey of more than 23,000 TDA followers found 11% of young people have used Ozempic or a similar drug, while 43% of respondents said they want to (or have previously wanted to) try weight-loss medication.

The first two episodes of Investigating Ozempic are available now wherever you get your podcasts, with part three out tomorrow, May 21.